Developer docs
API playgroundTry for free, no card

Search company profiles

Anervea.AI

Full company profile

uuid0043gff

Namestring
Anervea.AI
Legal namestring
Anervea Data Labs Private Limited
Websiteurl
anervea.ai
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Anervea.AI is a privately held AI software company founded in 2021 and headquartered in Pune, India, with additional offices in Philadelphia, Gurgaon, and Manila. The company builds AI-powered workflows and analytics platforms for BioPharma commercialization and clinical development, targeting pharmaceutical, biotechnology, and medical technology customers across global markets.

The core product stack comprises alfakinetic™ (real-time competitive intelligence and KOL mapping), alfaTRx™ (AI-powered market intelligence with automated patient journeys, HCP segmentation, and predictive next-best-action recommendations), and alfadev™ (product pipeline management). Supporting modules include alfaSage (conversational analytics), alfaCI (competitive intelligence tracking), alfalytics BI (business intelligence dashboards), and an AI InsightWizard. The technology layer is built on fine-tuned GPT-4o and GPT 4.1 nano models trained on pharma-specific data, terminology, and business logic, combined with gradient-boosted trees and transformer architectures for predictive forecasting. Data inputs span web scraping, social media, clinical trial databases, patent filings, regulatory documents, claims data, and prescription records. Reported outcomes include 25% improvement in KOL identification, 80% reduction in reporting costs, and mapping of 200+ KOLs and 32+ Centers of Excellence.

Anervea.AI monetizes through enterprise SaaS subscriptions sold via direct field sales and inside sales, complemented by an Advisory Services line covering strategic planning, competitive intelligence, commercial optimization, and advanced analytics. Pricing is custom and not publicly disclosed. The platform is ISO 27001 certified and compliant with GDPR, CCPA, and HIPAA. The company was founded by Ayush Mishra (CEO) and is led by a team blending pharma domain expertise (Chief Advisor Dr. Mimi Fenton; AVP Competitive Intelligence Shingitha K Palli) with AI engineering (Director of Engineering & AI Mac Ignacio; Head of Engineering & Data Science Lead Aniket Bhalerao).

Short descriptiontext

Anervea.AI provides AI-powered workflows and analytics platforms for BioPharma commercialization and clinical development, targeting pharmaceutical, biotech, and MedTech companies with custom enterprise subscriptions built on fine-tuned pharma-specific GPT models.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPhiladelphia, United States
HQ citystring
Philadelphia
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharma competitive intelligence, biopharma commercialization analytics, healthcare AI platform, HCP segmentation software, pharma market intelligence
Industry4 codes
PRIMARYHDAEANAA
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAF
AI Observability, Monitoring & Evaluation Platforms (Drift, Quality, Safety)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAG
Responsible AI, Security & Privacy Platforms (Safety, Guardrails, PII)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAI
AI Integration & Orchestration Platforms (Connectors, Workflow, iPaaS for AI)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
NAICS code2 codes
  • Software Publishers513210
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming Services7371
Product category
Pharmaceutical Commercialization Analytics Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1AI-Powered SaaS Platform Subscriptions
TypeSubscription Recurring
Description

Subscription-based access to AI-powered analytics and competitive intelligence platforms including alfaKinetic, alfaTRx, and alfaSage. Pricing is outlined on the website or in custom agreements, suggesting enterprise licensing with tiered or customized pricing.

anervea.ai
2Enterprise AI Solutions
TypeSubscription Recurring
Description

Customized AI solutions engineered for BioPharma excellence, sold as enterprise engagements with custom agreements.

anervea.ai
3Advisory Services
TypeProfessional Services
Description

Expert-led advisory services for market strategy, competitive intelligence, commercial optimization, and advanced analytics, provided as professional consulting engagements.

anervea.ai
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Pricing details1 tier
1Enterprise subscription with custom pricing
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Custom enterprise agreements; no public pricing tier listing available

anervea.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 7 records shown
1alfakinetic™
Description

Real-time competitive intelligence platform for BioPharma, delivering targeted intelligence for therapeutic focus and go-to-market processes.

anervea.ai
+6 more records
Core offering1 text field

Anervea.AI provides AI-powered SaaS platforms purpose-built for BioPharma commercialization, delivering real-time competitive intelligence, market intelligence, patient journey mapping, HCP segmentation, and predictive next-best-action recommendations. Its core products include alfakinetic (competitive intelligence and KOL mapping), alfaTRx (market intelligence with predictive analytics), alfadev (product pipeline management), and complementary advisory services for commercial strategy and competitive intelligence consulting.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 25% improvement in KOL identification for global pharma company launch
+6 more records
Product overview1 text field

Anervea.AI offers a comprehensive Pharma AI Stack consisting of core platforms and specialized modules. The primary products are alfakinetic™ for real-time competitive intelligence and KOL mapping, and alfaTRx™ for AI-powered market intelligence and HCP segmentation. These platforms are built on proprietary fine-tuned GPT models and utilize advanced ML for predictive analytics. Additional offerings include alfa dev™ for product pipeline management and Enterprise Pharma AI for customized enterprise solutions. The platform suite also includes sub-products alfaSage (conversational analytics), alfalytics BI (business intelligence dashboards), and alfaCI (competitive intelligence tracking). Advisory Services round out the portfolio with consulting capabilities spanning strategic planning, competitive intelligence, commercial optimization, and advanced analytics.

Product and service8 records
1alfakinetic
CategoryCompetitive Intelligence Platform
Description

Real-time competitive intelligence platform that delivers targeted intelligence for therapeutic focus areas, enabling smarter, faster, and more confident go-to-market processes. Features AI-powered KOL mapping, competitor monitoring, and early signal detection for strategic decision-making, designed for pharmaceutical commercial teams.

2alfaTRx
CategoryMarket Intelligence Platform
Description

AI-powered Market Intelligence platform for BioPharmaceutical commercialization. Provides automated patient journeys and HCP segmentation, predictive next-best-action recommendations, and an AI Wizard conversational interface for market research, prescribing patterns, and target market analytics. Built on fine-tuned GPT-4o and GPT 4.1 nano models trained on pharma-specific data.

3alfadev
CategoryPipeline Management Platform
Description

Platform for product pipeline management designed for BioPharma's evolving needs, enabling companies to track and manage their drug development and commercialization pipeline.

4Enterprise Pharma AI
CategoryEnterprise AI Solutions
Description

Customized AI solutions engineered for BioPharma excellence, providing tailored artificial intelligence capabilities and custom enterprise engagements for large pharmaceutical organizations.

5alfaSage
CategoryConversational Analytics
Description

AI-driven conversational analytics interface for pharma data, enabling users to query and interact with pharmaceutical datasets through natural language.

6alfalytics BI
CategoryBusiness Intelligence Dashboards
Description

Custom dashboards and advanced business intelligence platform that transforms raw claims and commercial data into strategic insights and executive-ready reporting.

7alfaCI
CategoryCompetitive Intelligence Module
Description

Competitive intelligence module providing real-time pharma market tracking, KOL profile management, and continuous monitoring of competitor activities across digital platforms and social media.

8Advisory Services
CategoryConsulting Services
Description

AI-powered commercial strategy consulting including strategic planning and market readiness, competitive intelligence and monitoring, commercial and sales optimization, marketing effectiveness and ROI, incentive compensation design, and advanced analytics and visualization. Provided as professional consulting engagements for pharmaceutical companies.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Xtalks
Strategic tierCoreTypeGTM or Marketing Partner
Description

Xtalks is a webinar and educational content partner hosting Anervea executives as speakers on AI in pharma competitive intelligence. This partnership positions Anervea as a thought leader and provides access to Xtalks' pharmaceutical industry audience through co-hosted educational webinars.

prnewswire.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

IQVIA is the largest commercial analytics and RWE platform for life sciences, offering competitive intelligence, HCP/patient analytics, and market access solutions. It overlaps directly with Anervea's alfakinetic and alfaTRx across pharma commercial workflows.

TypeDirect peer
Description

Trinity Life Sciences offers competitive intelligence, market access, and commercial strategy analytics for pharma/biotech. Directly overlaps with Anervea's CI, market access, and commercial analytics offerings.

TypeBroad incumbent
Description

Salesforce Health Cloud provides a broad CRM and analytics platform used by life sciences for HCP engagement and patient services. While not pharma-specialized, it competes for the same enterprise pharma IT budget as Anervea's commercial analytics suite.

TypeEmerging player
Description

Komodo Health is a real-world data and analytics platform mapping patient journeys and HCP behavior; it is referenced as a data partner in Anervea's short description and offers overlapping patient journey and HCP analytics capabilities.

TypeBroad incumbent
Description

Citeline/Informa Pharma Intelligence delivers competitive intelligence, clinical trial, regulatory, and pipeline data for pharma — directly comparable to Anervea's alfakinetic CI and alfadev pipeline offerings.

TypeDirect peer
Description

Eularis provides AI-driven commercial analytics and strategy consulting for pharma, focused on launch effectiveness and customer engagement — comparable to Anervea's advisory and predictive analytics stack.

TypeDirect peer
Description

Definitive Healthcare provides commercial intelligence, HCP/patient analytics, and real-world data for the healthcare and life sciences industry. Overlaps with Anervea's competitive intelligence and market access offerings.

8ZS Associates
TypeDirect peer
Description

ZS is a major pharma commercial analytics firm offering AI-driven sales force effectiveness, next-best-action engines, and patient analytics — directly comparable to Anervea's predictive NBA and HCP segmentation offerings.

TypeDirect peer
Description

Aktana provides AI-driven next-best-action and HCP engagement optimization for pharma commercial teams. Closely comparable to Anervea's predictive NBA engine and field force deployment use cases.

TypeBroad incumbent
Description

Veeva provides CRM, data, and commercial cloud platforms purpose-built for life sciences, including HCP engagement, field force enablement, and claims data. Its commercial suite overlaps with Anervea's market access and HCP segmentation capabilities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Anervea.AI

Pharmaceutical Commercialization Analytics Softwareanervea.ai

Anervea.AI provides AI-powered workflows and analytics platforms for BioPharma commercialization and clinical development, targeting pharmaceutical, biotech, and MedTech companies with custom enterprise subscriptions built on fine-tuned pharma-specific GPT models.

What Anervea.AI does

Anervea.AI is a privately held AI software company founded in 2021 and headquartered in Pune, India, with additional offices in Philadelphia, Gurgaon, and Manila. The company builds AI-powered workflows and analytics platforms for BioPharma commercialization and clinical development, targeting pharmaceutical, biotechnology, and medical technology customers across global markets.

The core product stack comprises alfakinetic™ (real-time competitive intelligence and KOL mapping), alfaTRx™ (AI-powered market intelligence with automated patient journeys, HCP segmentation, and predictive next-best-action recommendations), and alfadev™ (product pipeline management). Supporting modules include alfaSage (conversational analytics), alfaCI (competitive intelligence tracking), alfalytics BI (business intelligence dashboards), and an AI InsightWizard. The technology layer is built on fine-tuned GPT-4o and GPT 4.1 nano models trained on pharma-specific data, terminology, and business logic, combined with gradient-boosted trees and transformer architectures for predictive forecasting. Data inputs span web scraping, social media, clinical trial databases, patent filings, regulatory documents, claims data, and prescription records. Reported outcomes include 25% improvement in KOL identification, 80% reduction in reporting costs, and mapping of 200+ KOLs and 32+ Centers of Excellence.

Anervea.AI monetizes through enterprise SaaS subscriptions sold via direct field sales and inside sales, complemented by an Advisory Services line covering strategic planning, competitive intelligence, commercial optimization, and advanced analytics. Pricing is custom and not publicly disclosed. The platform is ISO 27001 certified and compliant with GDPR, CCPA, and HIPAA. The company was founded by Ayush Mishra (CEO) and is led by a team blending pharma domain expertise (Chief Advisor Dr. Mimi Fenton; AVP Competitive Intelligence Shingitha K Palli) with AI engineering (Director of Engineering & AI Mac Ignacio; Head of Engineering & Data Science Lead Aniket Bhalerao).

Anervea.AI firmographics

Firmographics
Name
Anervea.AI
Legal name
Anervea Data Labs Private Limited
Website
https://anervea.ai
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
51–100 employees
Short description
Anervea.AI provides AI-powered workflows and analytics platforms for BioPharma commercialization and clinical development, targeting pharmaceutical, biotech, and MedTech companies with custom enterprise subscriptions built on fine-tuned pharma-specific GPT models.
Ownership category
akta.pro rank

Anervea.AI industry classification

Industry
Product category
Pharmaceutical Commercialization Analytics Software
NAICS
Software Publishers (513210), Computer Systems Design and Related Services (54151)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming Services (7371)
akta.pro industry
PRIMARYHDAEANAA
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAF
AI Observability, Monitoring & Evaluation Platforms (Drift, Quality, Safety)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAG
Responsible AI, Security & Privacy Platforms (Safety, Guardrails, PII)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAI
AI Integration & Orchestration Platforms (Connectors, Workflow, iPaaS for AI)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise

Keywords

  • Pharma competitive intelligence
  • Biopharma commercialization analytics
  • Healthcare AI platform
  • HCP segmentation software
  • Pharma market intelligence

Where Anervea.AI is headquartered

Location

Headquarters

HQ city
Philadelphia
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Anervea.AI business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. AI-Powered SaaS Platform Subscriptions: Subscription-based access to AI-powered analytics and competitive intelligence platforms including alfaKinetic, alfaTRx, and alfaSage. Pricing is outlined on the website or in custom agreements, suggesting enterprise licensing with tiered or customized pricing.
  2. Enterprise AI Solutions: Customized AI solutions engineered for BioPharma excellence, sold as enterprise engagements with custom agreements.
  3. Advisory Services: Expert-led advisory services for market strategy, competitive intelligence, commercial optimization, and advanced analytics, provided as professional consulting engagements.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise subscription with custom pricing

Go-to-market motion1 record

Distribution channels3 records

Marketing channels9 records

Anervea.AI product offering

Product offering

Core offering

Anervea.AI provides AI-powered SaaS platforms purpose-built for BioPharma commercialization, delivering real-time competitive intelligence, market intelligence, patient journey mapping, HCP segmentation, and predictive next-best-action recommendations. Its core products include alfakinetic (competitive intelligence and KOL mapping), alfaTRx (market intelligence with predictive analytics), alfadev (product pipeline management), and complementary advisory services for commercial strategy and competitive intelligence consulting.

Product overview

Anervea.AI offers a comprehensive Pharma AI Stack consisting of core platforms and specialized modules. The primary products are alfakinetic™ for real-time competitive intelligence and KOL mapping, and alfaTRx™ for AI-powered market intelligence and HCP segmentation. These platforms are built on proprietary fine-tuned GPT models and utilize advanced ML for predictive analytics. Additional offerings include alfa dev™ for product pipeline management and Enterprise Pharma AI for customized enterprise solutions. The platform suite also includes sub-products alfaSage (conversational analytics), alfalytics BI (business intelligence dashboards), and alfaCI (competitive intelligence tracking). Advisory Services round out the portfolio with consulting capabilities spanning strategic planning, competitive intelligence, commercial optimization, and advanced analytics.

Differentiator

Problem solved

Functional benefit

Brands

  • alfakinetic™: Real-time competitive intelligence platform for BioPharma, delivering targeted intelligence for therapeutic focus and go-to-market processes.
  • alfaTRx™
  • alfadev™
  • alfa Sage
  • alfaCI
  • alfalytics BI
  • AI InsightWizard

Products and services

  • alfakinetic Real-time competitive intelligence platform that delivers targeted intelligence for therapeutic focus areas, enabling smarter, faster, and more confident go-to-market processes. Features AI-powered KOL mapping, competitor monitoring, and early signal detection for strategic decision-making, designed for pharmaceutical commercial teams.
  • alfaTRx AI-powered Market Intelligence platform for BioPharmaceutical commercialization. Provides automated patient journeys and HCP segmentation, predictive next-best-action recommendations, and an AI Wizard conversational interface for market research, prescribing patterns, and target market analytics. Built on fine-tuned GPT-4o and GPT 4.1 nano models trained on pharma-specific data.
  • alfadev Platform for product pipeline management designed for BioPharma's evolving needs, enabling companies to track and manage their drug development and commercialization pipeline.
  • Enterprise Pharma AI Customized AI solutions engineered for BioPharma excellence, providing tailored artificial intelligence capabilities and custom enterprise engagements for large pharmaceutical organizations.
  • alfaSage AI-driven conversational analytics interface for pharma data, enabling users to query and interact with pharmaceutical datasets through natural language.
  • alfalytics BI Custom dashboards and advanced business intelligence platform that transforms raw claims and commercial data into strategic insights and executive-ready reporting.
  • alfaCI Competitive intelligence module providing real-time pharma market tracking, KOL profile management, and continuous monitoring of competitor activities across digital platforms and social media.
  • Advisory Services AI-powered commercial strategy consulting including strategic planning and market readiness, competitive intelligence and monitoring, commercial and sales optimization, marketing effectiveness and ROI, incentive compensation design, and advanced analytics and visualization. Provided as professional consulting engagements for pharmaceutical companies.

Quantifiable outcome

  • 25% improvement in KOL identification for global pharma company launch
  • +6 more outcomes

Companies that use Anervea.AI

Customer profile

Segments3 records

Ideal customer profiles2 records

Anervea.AI technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature6 records

Anervea.AI partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • XtalkscoreGTM or Marketing PartnerXtalks is a webinar and educational content partner hosting Anervea executives as speakers on AI in pharma competitive intelligence. This partnership positions Anervea as a thought leader and provides access to Xtalks' pharmaceutical industry audience through co-hosted educational webinars.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Anervea.AI competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: IQVIA is the largest commercial analytics and RWE platform for life sciences, offering competitive intelligence, HCP/patient analytics, and market access solutions. It overlaps directly with Anervea's alfakinetic and alfaTRx across pharma commercial workflows.
  • Salesforce Health Cloud: Salesforce Health Cloud provides a broad CRM and analytics platform used by life sciences for HCP engagement and patient services. While not pharma-specialized, it competes for the same enterprise pharma IT budget as Anervea's commercial analytics suite.
  • Informa Pharma Intelligence (Citeline): Citeline/Informa Pharma Intelligence delivers competitive intelligence, clinical trial, regulatory, and pipeline data for pharma — directly comparable to Anervea's alfakinetic CI and alfadev pipeline offerings.
  • Veeva Systems: Veeva provides CRM, data, and commercial cloud platforms purpose-built for life sciences, including HCP engagement, field force enablement, and claims data. Its commercial suite overlaps with Anervea's market access and HCP segmentation capabilities.

Direct peers

  • Trinity Life Sciences: Trinity Life Sciences offers competitive intelligence, market access, and commercial strategy analytics for pharma/biotech. Directly overlaps with Anervea's CI, market access, and commercial analytics offerings.
  • Eularis: Eularis provides AI-driven commercial analytics and strategy consulting for pharma, focused on launch effectiveness and customer engagement — comparable to Anervea's advisory and predictive analytics stack.
  • Definitive Healthcare: Definitive Healthcare provides commercial intelligence, HCP/patient analytics, and real-world data for the healthcare and life sciences industry. Overlaps with Anervea's competitive intelligence and market access offerings.
  • ZS Associates: ZS is a major pharma commercial analytics firm offering AI-driven sales force effectiveness, next-best-action engines, and patient analytics — directly comparable to Anervea's predictive NBA and HCP segmentation offerings.
  • Aktana: Aktana provides AI-driven next-best-action and HCP engagement optimization for pharma commercial teams. Closely comparable to Anervea's predictive NBA engine and field force deployment use cases.

Emerging players

  • Komodo Health: Komodo Health is a real-world data and analytics platform mapping patient journeys and HCP behavior; it is referenced as a data partner in Anervea's short description and offers overlapping patient journey and HCP analytics capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Anervea.AI social profiles

Digital presence

Anervea.AI compliance and trust

Trust signal

Compliance4 records

Anervea.AI financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Anervea.AI leadership team

Management profile

Number of profiles

Profiles9 records

Anervea.AI funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Anervea.AI M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Anervea.AI

What does Anervea.AI do?

Anervea.AI provides AI-powered SaaS platforms purpose-built for BioPharma commercialization, delivering real-time competitive intelligence, market intelligence, patient journey mapping, HCP segmentation, and predictive next-best-action recommendations. Its core products include alfakinetic (competitive intelligence and KOL mapping), alfaTRx (market intelligence with predictive analytics), alfadev (product pipeline management), and complementary advisory services for commercial strategy and competitive intelligence consulting.

Is Anervea.AI a public or private company?

Anervea.AI is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Anervea.AI founded?

Anervea.AI was founded in 2022. It employs 51 to 100 people.

Where is Anervea.AI based?

Anervea.AI is headquartered in Philadelphia, United States, in the North America region.

How does Anervea.AI make money?

Three revenue lines are on record. AI-Powered SaaS Platform Subscriptions are the primary driver. The others are enterprise AI Solutions and advisory Services.

Who are Anervea.AI's main competitors?

Broad incumbents on record are IQVIA, Salesforce Health Cloud, Informa Pharma Intelligence (Citeline) and Veeva Systems. Direct peers are Trinity Life Sciences, Eularis, Definitive Healthcare, ZS Associates and Aktana. Komodo Health is listed as an emerging player.

Does Anervea.AI have an API?

No public API is recorded for Anervea.AI.

What industry is Anervea.AI in?

Anervea.AI's product category is Pharmaceutical Commercialization Analytics Software. Its primary akta.pro industry code is HDAEANAA, End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management), with a secondary code of HDAEANAF, AI Observability, Monitoring & Evaluation Platforms (Drift, Quality, Safety). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireBeyond Monitoring: How AI Is Turning Pharma CI into a Commercial Decision Engine, Upcoming Webinar Hosted by XtalksXtalks is hosting a free webinar on June 2, 2026 titled 'Beyond Monitoring: How AI Is Turning Pharma CI into a Commercial Decision Engine,' featuring Anervea.AI executives Dr. Sanika Bhide and Stephen Shewbrooks as speakers. The webinar will address the limitations of fragmented competitive intelligence models in pharma organizations and present a unified three-layer CI architecture combining global public data, proprietary primary intelligence, and custom per-function decision workflows. The event targets pharma, biotech, and medtech professionals seeking to transform competitive intelligence from a support function into enterprise-wide decision infrastructure.AnerveaKey Metrics and KPI's for Measuring Success in Pharma CommercializationThe article outlines key performance indicators for measuring success in pharmaceutical commercialization, emphasizing the role of AI-enabled data analytics in tracking metrics such as market revenue share, prescription data, and patient adherence. It highlights that sales teams using AI are significantly more likely to see revenue increases compared to those not utilizing these technologies. The piece concludes by promoting Anervea's proprietary AI tools, alfaTRx™ and alfakinetic™, designed to help BioPharma companies optimize their commercialization strategies.TmcnetAnervea Welcomes Jack Capponi as Chief Commercial Officer and Board Member, Driving Global Expansion with AI-Powered SolutionsAnervea.ai appointed Jack Capponi as Chief Commercial Officer and board member, leveraging his 20+ years of biotech and pharma leadership. He will drive global expansion of AI-powered commercialization platforms Alfa CI and Alfa Sage across U.S. and EU markets.PR NewswireAnervea Welcomes Jack Capponi as Chief Commercial Officer and Board Member, Driving Global Expansion with AI-Powered SolutionsAnervea.ai appointed Jack Capponi as Chief Commercial Officer and board member, leveraging his 20+ years of biotech and pharma leadership. He previously launched 13 global products and will drive expansion in U.S. and EU markets. The company's AI-powered platforms Alfa CI and Alfa Sage will support this growth.PR NewswireAnervea Welcomes Jack Capponi as Chief Commercial Officer and Board Member, Driving Global Expansion with AI-Powered SolutionsAnervea.ai appointed Jack Capponi as Chief Commercial Officer and board member, leveraging his 20+ years of biotech and pharma leadership. He will drive global expansion across U.S. and EU markets, building on the company's AI-powered commercialization platforms Alfa CI and Alfa Sage.TmcnetEmpowering Anervea: A Catalyst for Transformative Insights in the Pharmaceutical ArenaAnervea promotes its competitive intelligence services for pharmaceutical companies, highlighting AI and machine learning integration. The body cites market projections: AI in healthcare reaching $120.2 billion by 2028, advanced-data analytics platforms at $67.82 billion by 2025, and cloud computing in healthcare at $64.7 billion by 2025.GlobeNewswireAnervea Spearheads Growth in India's Booming Dermatology Market Post-COVID, Aiming to Enhance Pharmaceutical Sales and Marketing EffectivenessAnervea, an analytics provider, is targeting India's post-COVID dermatology market, which is valued at over $750 million and growing at over 12% annually. The market is projected to surpass $2 billion by 2030, driven by rising skin disease prevalence and D2C brand growth. Anervea's database of 20,000 dermatologists aims to help pharma firms optimize sales and marketing.The Times of IndiaAlpha {.dev}: Hyper-local markets represent growth markets for Indian pharmaceutical companies, ET HealthWorldAnervea's Ayush Atul Mishra discussed how data science evolved during the pandemic, enabling drug repurposing and epidemiological modeling. He highlighted hyper-local markets in tier III-IV cities as growth areas, and described Alpha {.dev} as a pin-code-level mapping tool for doctors, hospitals, and pharmacies. Future trends include advanced analytics, personalized marketing, and real-time data-driven decision-making.The Times of IndiaAnervea: Revolutionising Indian healthcare industry through power of data, ET HealthWorldAnervea, a data analytics company, provides commercial solutions for Indian pharmaceutical companies, including market research, location-based intelligence, and sales force effectiveness. Its product Alpha maps doctors, hospitals, and pharmacies at the pin code level to target hyper-local growth markets. The company aims to improve commercial operations and patient outcomes through data-driven insights.